• Mon news: Novartis in $745M radiopharma pact. Novo launches Wegovy in China. COVID-era telehealth prescribing extended. Hims & Hers GLP-1 tracker. Promising Gilead liver disease trial. See more on our front page

Medtronic has killed Uroplasty





















Uroplasty has nobody to fault but themselves - weak leadership. What they shoud do is go recruit some former MDT Neuro people who have concept sale experience and know how to develop a market.
 












Yep that too!

Interstim managment team are a bunch of bozos. Those true colors will come to light once they have a legit competitve therapy that's shows comparable clinical benefit and professional fee reimbursement. You know what the really scary part is about the Interstim management team? They actually think they're good at what they do!
 
















Let's start with Kern, then Pennington, and let's not forget Eric.

Not sure Pennington and Eric are as flawed as Kern. I mean this guy has SERIOUS character issues and most know it except for HR being they change seats so often. His file cannot be pretty. Must have threatened the company with some type of lawsuit.